Teicoplanin combined with conventional vancomycin therapy for the treatment of pulmonary methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis infections
Wei Wu, Jia-Jing Geng, Mei Wang, Laboratory Medicine, Bejing Tongren Hospital, Capital Medical University, Beijing 100176, China
Min Liu, Department of General Practice, The Community Health Services Center in Lumen, Beijing 100080, China
Author contributions: Wu W and Wang M designed the research study; Liu M performed the research; Geng JJ analyzed the data and wrote the manuscript.
Institutional review board statement: The study was reviewed and approved by the Beijing Tongren Hospital, Capital Medical University Institutional Review Board (Approval No. TRECKY2020-100).
Informed consent statement: All study participants provided informed written consent prior to study enrollment.
Conflict-of-interest statement: No conflict of interest.
Data sharing statement: No additional data are available.
: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Mei Wang, MHSc, Attending Doctor, Laboratory Medicine, Bejing Tongren Hosptial, Capital Medical University, No. 2 West Ring South Road, Beijing 100176, China. email@example.com
Received: July 28, 2021
Peer-review started: July 28, 2021
First decision: August 19, 2021
Revised: August 24, 2021
Accepted: October 14, 2021
Article in press: October 14, 2021
Published online: December 6, 2021